High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses

Dengue virus (DENV) threatens almost 70% of the world’s population, with no effective therapeutic currently available and controversy surrounding the one approved vaccine. A key factor in dengue viral replication is the interaction between DENV nonstructural proteins (NS) 5 and 3 (NS3) in the infected cell. Here, we perform a proof-of-principle high-throughput screen to identify compounds targeting the NS5-NS3 binding interface. We use a range of approaches to show for the first time that two small molecules–repurposed drugs I-OMe tyrphostin AG538 (I-OMe-AG238) and suramin hexasodium (SHS)–inhibit NS5-NS3 binding at low μM concentration through direct binding to NS5 that impacts thermostability. Importantly, both have strong antiviral activity at low μM concentrations against not only DENV-2, but also Zika virus (ZIKV) and West Nile virus (WNV). This work highlights the NS5-NS3 binding interface as a viable target for the development of anti-flaviviral therapeutics.

[1]  A. Gutiérrez-Escolano,et al.  Nuclear localization of non-structural protein 3 (NS3) during dengue virus infection , 2021, Archives of Virology.

[2]  D. Jans,et al.  Application of In Silico and HTS Approaches to Identify Nuclear Import Inhibitors for Venezuelan Equine Encephalitis Virus Capsid Protein: A Case Study , 2020, Frontiers in Chemistry.

[3]  Natacha S. Ogando,et al.  Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle , 2020, Antimicrobial Agents and Chemotherapy.

[4]  N. Borg,et al.  The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer. , 2020, Antiviral research.

[5]  J. Forwood,et al.  Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer , 2019, Cells.

[6]  Yang Wang,et al.  Identification of Drug Binding Sites and Action Mechanisms with Molecular Dynamics Simulations. , 2019, Current topics in medicinal chemistry.

[7]  K. Kehn-Hall,et al.  Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin &agr;/&bgr;1 heterodimer through high‐throughput screening , 2018, Antiviral research.

[8]  J. Salas-Benito,et al.  Strand-like structures and the nonstructural proteins 5, 3 and 1 are present in the nucleus of mosquito cells infected with dengue virus. , 2018, Virology.

[9]  D. Jans,et al.  Nucleocytoplasmic Trafficking of Dengue Non-structural Protein 5 as a Target for Antivirals. , 2018, Advances in experimental medicine and biology.

[10]  G. Moseley,et al.  Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V , 2018, Scientific Reports.

[11]  K. Kehn-Hall,et al.  Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug-Design , 2017, Scientific Reports.

[12]  B. Geiss,et al.  Organization of the Flavivirus RNA replicase complex , 2017, Wiley interdisciplinary reviews. RNA.

[13]  M. V. van Hemert,et al.  Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles , 2017, Antiviral research.

[14]  Nicolas Baurin,et al.  Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine. , 2016, Vaccine.

[15]  B. Schnierle,et al.  Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry , 2016, Virology Journal.

[16]  M. V. van Hemert,et al.  Suramin inhibits chikungunya virus replication through multiple mechanisms. , 2015, Antiviral research.

[17]  Tzong-Yuan Wu,et al.  Suramin Inhibits Chikungunya Virus Entry and Transmission , 2015, PloS one.

[18]  P. Lemey,et al.  New Insights into Flavivirus Evolution, Taxonomy and Biogeographic History, Extended by Analysis of Canonical and Alternative Coding Sequences , 2015, PloS one.

[19]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[20]  Moon Y. F. Tay,et al.  The C-terminal 50 Amino Acid Residues of Dengue NS3 Protein Are Important for NS3-NS5 Interaction and Viral Replication* , 2014, The Journal of Biological Chemistry.

[21]  P. Sexton,et al.  A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. , 2014, The Journal of infectious diseases.

[22]  P. Buchy,et al.  The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo , 2014, Emerging Microbes and Infections.

[23]  Moon Y. F. Tay,et al.  Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. , 2013, Antiviral research.

[24]  M. Platonov,et al.  Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening , 2013, Acta Naturae.

[25]  A. Ryo,et al.  Establishment of a robust dengue virus NS3-NS5 binding assay for identification of protein-protein interaction inhibitors. , 2012, Antiviral research.

[26]  M. Bolognesi,et al.  Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. , 2012, Journal of molecular biology.

[27]  D. Harrich,et al.  Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus , 2012, The Biochemical journal.

[28]  J. McCluskey,et al.  A Structural Basis for Varied αβ TCR Usage against an Immunodominant EBV Antigen Restricted to a HLA-B8 Molecule , 2012, The Journal of Immunology.

[29]  G. Moseley,et al.  Subcellular trafficking of pathogens: targeting for therapeutics , 2012 .

[30]  D. Jans,et al.  An AlphaScreen®-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import , 2011, Journal of biomolecular screening.

[31]  D. Jans,et al.  CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus Production* , 2009, The Journal of Biological Chemistry.

[32]  S. Vasudevan,et al.  Nuclear Localization of Dengue Virus Nonstructural Protein 5 Through Its Importin α/β–Recognized Nuclear Localization Sequences is Integral to Viral Infection , 2007, Traffic.

[33]  K. Murthy,et al.  Modulation of the Nucleoside Triphosphatase/RNA Helicase and 5′-RNA Triphosphatase Activities of Dengue Virus Type 2 Nonstructural Protein 3 (NS3) by Interaction with NS5, the RNA-dependent RNA Polymerase* , 2005, Journal of Biological Chemistry.

[34]  Bostjan Kobe,et al.  Structural Basis for the Specificity of Bipartite Nuclear Localization Sequence Binding by Importin-α* , 2003, Journal of Biological Chemistry.

[35]  D. Gubler.  The global emergence/resurgence of arboviral diseases as public health problems. , 2002, Archives of medical research.

[36]  S. Vasudevan,et al.  A small region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, confers interaction with both the nuclear transport receptor importin-beta and the viral helicase, NS3. , 2001, The Journal of general virology.

[37]  A. Levitzki,et al.  Substrate competitive inhibitors of IGF-1 receptor kinase. , 2000, Biochemistry.

[38]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[39]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[40]  M. Kuo,et al.  RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA , 1997, Journal of virology.

[41]  M. Ramachandra,et al.  Association between NS3 and NS5 Proteins of Dengue Virus Type 2 in the Putative RNA Replicase Is Linked to Differential Phosphorylation of NS5 (*) , 1995, The Journal of Biological Chemistry.